Clinical Presentation and Therapy of Atrial Septal Defect

Nikolaus A Haas; David J Driscoll; Silke Rickert-Sperling

doi:10.1007/978-3-031-44087-8_23

Clinical Presentation and Therapy of Atrial Septal Defect

Adv Exp Med Biol. 2024:1441:461-466. doi: 10.1007/978-3-031-44087-8_23.

Authors

Nikolaus A Haas¹, David J Driscoll², Silke Rickert-Sperling³

Affiliations

¹ Department of Pediatric Cardiology and Intensive Care, Ludwig Maximilians University, Munich, Germany. Nikolaus.haas@med.uni-muenchen.de.
² Division of Pediatric Cardiology, Department of Pediatrics, Mayo Clinic College of Medicine, Rochester, MN, USA.
³ Cardiovascular Genetics, Charité - Universitätsmedizin Berlin, Berlin, Germany.

PMID: 38884725
DOI: 10.1007/978-3-031-44087-8_23

Abstract

Atrial septal defects (ASDs) occur in 1 of 1500 live births and constitute 6-10% of congenital heart defects. There is a female-to-male predominance of 2 to 1. According to their embryological origins, we can differentiate five different types of ASDs (see Fig. 23.1).

Publication types

Review

MeSH terms

Female
Heart Septal Defects, Atrial* / diagnosis
Heart Septal Defects, Atrial* / therapy
Humans
Male